ANG Lifesciences India Limited share price
BSE: ANG
Key numbers
- Market cap
- ₹ 52.6 Cr
- Current price
- ₹ 40.27
- 52-week high / low
- ₹ 50 / 18
- Stock P/E
- -
- Book value
- ₹ 41.0
- Dividend yield
- 0.00%
- ROCE
- -3.6%
- ROE
- -19.0%
- Debt to equity
- 1.50
- Sales growth (3 yrs)
- -25.0%
- Profit growth (3 yrs)
- -
- 1-year return
- 18.0%
About ANG Lifesciences India Limited
ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company also offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 25 | 26 | 19 | 24 | 15 |
| Operating profit | 1 | 0 | -3 | 3 | -2 |
| Net profit | -2 | -3 | -5 | -1 | -4 |
| EPS (₹) | -1.54 | -2.26 | -3.64 | -1.06 | -3.25 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.